Social Activist Demands Lab Testing Of Ayurvedic Medicine Used For Joint Pains

Jammu: (UNI) A Jammu based social activist Sukesh C Khajuria has sought laboratory testing of Ayurvedic medicine, being used for treating the joint pains.

The social activist had expressed his apprehensions related to the Ayurvedic composition known as ‘Batnashak Batika”, which he claimed is increasingly being utilized for the treatment of joint pains, particularly in patients who have suffered from ‘Chikungunya’ in Jammu and Kashmir. He wrote to the drug authorities in J&K that ‘Batnashak Batika’ reportedly demonstrates swift efficacy in alleviating post-Chikungunya joint pains, contrary to the conventional understanding that Ayurvedic herbal medicines typically facilitate gradual healing and recovery.

Given the remarkable and expeditious healing attributed to this Ayurvedic medicine, I harbour reservations regarding its composition,” he added.

He requested the Drug controller Jammu and Kashmir to conduct a thorough chemical examination of the composition to determine whether any steroids or potentially harmful substances have been incorporated to expedite relief, posing potential health risks to consumers. Khajuria and urged the authorities for a comprehensive chemical examination of the Ayurvedic medicine at the drug laboratory and disseminate the findings to the general public for the collective benefit of society.

He said he had alerted the drug authorities of Jammu and Kashmir, Union Health Minister and other central and union territory officials about the dangers of sale of such drugs.

Related Posts

  • Pharma
  • April 30, 2025
  • 31 views
US FDA approves first cell-based gene therapy for rare genetic skin disorder

The U.S. Food and Drug Administration approved Abeona Therapeutics’ (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn, is approved to…

  • Pharma
  • April 30, 2025
  • 65 views
Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

New Delhi:  A recent study found that a daily exposure to phthalates, that is commonly used in making household plastic items, is linked to 3.5 lakh, or 13 per cent,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA approves first cell-based gene therapy for rare genetic skin disorder

US FDA approves first cell-based gene therapy for rare genetic skin disorder

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Cargologic receives CEIV Pharma re-certification

Cargologic receives CEIV Pharma re-certification

Dr. Reddy’s to introduce Sanofi’s novel RSV drug in India

Dr. Reddy’s to introduce Sanofi’s novel RSV drug in India